Plasminogen activator inhibitor-1 (PAI-1) 4G5G polymorphism and PAI-1 enzyme activity in young patients with ischemic stroke

被引：0
|
作者：
Santos, M. S. [1 ]
Sabino, A. P. [1 ]
Carvalho, M. G. [1 ]
Ribeiro, D. D. [2 ]
Gadelha, T. [2 ]
Dusse, L. S. [2 ]
Fernandes, A. P. [1 ]
机构：
[1] Univ Fed Minas Gerais, Clin & Toxicol Anal, Belo Horizonte, MG, Brazil
[2] Clin Hosp, Clin & Toxicol Anal, Belo Horizonte, MG, Brazil
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-MO-334
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [1] The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels
    Diamanti-Kandarakis, E
    Palioniko, G
    Alexandraki, K
    Bergiele, A
    Koutsouba, T
    Bartzis, M
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (06) : 793 - 798
  • [2] Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression
    Ramon, Luis A.
    Gilabert-Estelles, Juan
    Cosin, Raul
    Gilabert, Juan
    Espana, Francisco
    Castello, Remedios
    Chirivella, Melitina
    Romeu, Alberto
    Estelles, Amparo
    THROMBOSIS RESEARCH, 2008, 122 (06) : 854 - 860
  • [3] Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
    Adriano de Paula Sabino
    Daniel Dias Ribeiro
    Caroline Pereira Domingueti
    Mariana Silva dos Santos
    Telma Gadelha
    Luci Maria SantAna Dusse
    Maria das Graças Carvalho
    Ana Paula Fernandes
    Molecular Biology Reports, 2011, 38 : 5355 - 5360
  • [4] Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
    Sabino, Adriano de Paula
    Ribeiro, Daniel Dias
    Domingueti, Caroline Pereira
    dos Santos, Mariana Silva
    Gadelha, Telma
    SantAna Dusse, Luci Maria
    Carvalho, Maria das Gracas
    Fernandes, Ana Paula
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (08) : 5355 - 5360
  • [5] The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1
    van der Bom, JG
    Bots, ML
    Haverkate, F
    Kluft, C
    Grobbee, DE
    BLOOD, 2003, 101 (05) : 1841 - 1844
  • [6] Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity
    Gilabert-Estelles, Juan
    Ramon, Luis A.
    Braza-Boils, Aitana
    Gilabert, Juan
    Chirivella, Melitina
    Espana, Francisco
    Estelles, Amparo
    THROMBOSIS RESEARCH, 2012, 130 (02) : 242 - 247
  • [7] Association of plasminogen activator inhibitor-1 (PAI-1) gene promoter 4G/5G polymorphism with plasma PAI-1 level in patients with hypertension
    Jeng, JR
    Harn, HJ
    Shieh, SM
    ATHEROSCLEROSIS, 1999, 144 : 64 - 64
  • [8] Plasminogen activator inhibitor type 1 (PAI-1) level and activity at patients with PAI-1 polymorphism
    Shelest, A.
    Matveeva, M. A.
    Popova, L., V
    Patrushev, L., I
    Shuganov, E. G.
    Gneusheva, T. Y.
    Bokarev, I. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1173 - 1173
  • [9] PAI-1 4G/5G polymorphism and PAI-1 plasma levels in ischemic stroke
    De Lucia, D
    Del Giudice, V
    Maisto, G
    De Francesco, F
    Fratta, M
    Quarantiello, M
    Caiazzo, P
    Papa, ML
    Margaglione, M
    Toso, V
    Majello, L
    Santangelo, R
    De Falco, FA
    NEUROLOGY, 2001, 56 (08) : A168 - A169
  • [10] Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
    L Lorente
    M Martín
    L Labarta
    C Díaz
    J Solé-Violán
    J Blanquer
    J Borreguero
    Y Barrios
    Critical Care, 13 (Suppl 1):
12345